Newsroom

November 18, 2026

News

Johanna Säll joins Disruptive Pharma as Analytical Chemist

Johanna Säll

Disruptive Pharma is pleased to welcome Johanna Säll as Analytical Chemist. She joins our R&D team in Uppsala, where she will support the development and evaluation of oral drug formulations using Formulite® in both internal and partner projects.

Johanna joins us with several years of experience from Novavax and Fresenius Kabi, bringing valuable expertise in analytical development, quality control and HPLC.

Analytical chemistry is an integral part of how we develop and evaluate Formulite® formulations. As we expand our collaborations with pharmaceutical and biotechnology partners, this expertise becomes increasingly important. Each project brings a different compound and different development goals, and the analytical methods need to answer the questions that matter for that project.

Working closely with our formulation scientists, Johanna will play an important role in the development and evaluation of Formulite® formulations, supporting both our internal projects and collaborations with pharmaceutical partners.
Welcome to the team, Johanna! We’re delighted to have you with us!